Table 4 Results of survival analysis
Relevant factors | n (%) | Mean survival (mean ± SD, range) (months) | p-value |
|---|---|---|---|
Nutritional status | |||
GroupNS | 46 (56.8%) | 58.91 ± 3.83 (4–75 ± 18.79) | 0.045 |
GroupControl | 35 (43.2%) | 43.49 ± 4.61 (6–66 ± 15.7) | - |
Sex | |||
Male | 68 (84%) | 50.86 ± 3.74 (4–75 ± 17.97) | 0.110 |
Female | 13 (16%) | 59.10 ± 4.36 (18–66 ± 15.84) | |
Histopathological diagnosis | |||
Adenocarcinoma | 41 (50.6%) | 56.02 ± 4.22 (4–74 ± 17.72) | 0.308 |
Squamous cell carcinoma | 40 (49.4%) | 51.24 ± 4.96 (6–75 ± 18.27) | |
Surgical procedure | |||
Pneumonectomy | 20 (24.7%) | 50.69 ± 3.94 (4–75 ± 18.38) | 0.151 |
Non-pneumonectomy | 61 (75.3%) | 61.99 ± 5.45 (5–75 ± 17.52) | |